Public Health News Roundup: May 18
The Centers for Disease Control and Prevention (CDC) has designated Saturday, May 19, as the first ever Hepatitis Testing Day to remind health care providers and the public about who should be tested for chronic viral hepatitis. Millions of Americans have the condition but don’t know they’re infected. The CDC recommends starting with their five-minute online assessment. Read more on infectious disease.
The U.S. Food and Drug Administration (FDA) has approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
The drug is approved to treat patients who have had a recent heart attack or stroke, or have partial or total blockage of an artery.
“For people who must manage chronic health conditions, having effective and affordable treatment options is important,” said Keith Webber, PhD, deputy director of the Office of Pharmaceutical Science in the FDA’s Center for Drug Evaluation and Research. “The generic products approved today will expand those options for patients.” Read more on prescription drugs.
The Associated Press is reporting that a man from San Joaquin County, Calif., has been arrested for refusing to comply with a drug regimen to treat tuberculosis. The arrest was requested by the county’s nursing director.